The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
. Faculty in the department are involved with a wide variety of standard of care and experimental cellular therapy applications including hematopoietic stem cell transplant, regulatory T cell therapy
-
Sciences; Health Sciences; Health System; Chief Financial Officer; Advancement; Resource Management and Planning. As part of UC San Diego, Sanford Stem Cell Institute motivates University-wide change
-
HSCT and CAR-T Cell Therapy BMT and CAR-T cell therapy patient population knowledge Minimum 6 months experience working as an RN in an Inpatient or Outpatient Oncology setting OR 1 Year clinical
-
Practice Facility (GMP) and clients of the GMP, the Alpha Stem Cell Clinic, the CAR-T Manufacturing Program within the Stem Cell Program and Gene Therapy Center, and multiple University of California
-
the immune response of T cell genes and their products in the context of autoimmunity, anti-tumor immunity, anti-viral immunity, and antibody-mediated rejection. The Dana-Farber Cancer Institute is a major
-
Jersey in Christian Hinrichs’s laboratory to conduct research on tumor immunology with a focus on the discovery and development of T cell therapy for cancer, including tumor-infiltrating lymphocytes and
-
Inclusion; Student Affairs; Marine Sciences; Health Sciences; Health System; Chief Financial Officer; Advancement; Resource Management and Planning. As part of UC San Diego, Sanford Stem Cell Institute
-
| Comprehensive Cancer Center Dr. Ebrahimi-Nik’s Laboratory, situated within the Ohio State University Comprehensive Cancer Center (OSUCCC) and the Pelotonia Institute for Immuno-Oncology (PIIO), is devoted
-
responses are required for sustained protective anti-tumor responses, tumor infiltrating CD8+ T cells which have the potential to control tumor growth, often acquire a dysfunctional state due to chronic
-
to gain a deeper understanding of challenges associated with T cell-based immunotherapies such as CAR-T cells and develop novel strategies to improve safety and efficacy of T cell therapies. Learning